Beem stock premarket
Net income for the quarter came in at $8.43 million, while revenues rose by 99.88% to $51.07 million. A lower net income was reported in the quarter under review than the previous quarter. Earnings SurpriseĪccording to Beam Therapeutics Inc.’s quarterly financial report for the quarter that ended March 30. In the meantime, the return on equity (ROE) for the last 12 months was -31.20%. There was a -47.20% return on investment (ROI) in the past year. BEAM’s return on assets (ROA) during the last 12 months has been -19.10%. Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. Based on annual data, it had gross profit of $51.84 million and revenue of $51.84 million. Financial Healthįor the three months ended March 30, Beam Therapeutics Inc.’s quick ratio was 5.70, while its current ratio was 5.70, indicating its ability to pay off its debt. Valuation MetricsĬompany paid $0.2250 per share in dividends, remained unchanged from $0.2250 last year. The transaction was completed for $981,205. See Remark 1 FMR LLC had earlier sold 19,466 shares on Apr 13 for $50.41 a share. After the transaction, the insider now owns 1,118,520 shares. sold 30,000 shares at a price of US$37.98. This transaction resulted in the insider making $759,597. (BEAM) last reported insider trading activity on Apr 28. There have been 83 days since Beam Therapeutics Inc. Get your free portfolio today before it's too late. That's why we laid out The 2022 Ultimate Gold Portfolio – to dissect the treasure from the trash. The bad news is there's still a TON of junk out there.
![beem stock premarket beem stock premarket](https://9t9263ixfxx10z7mr1axwfp1-wpengine.netdna-ssl.com/wp-content/uploads/2020/12/wpqk-600x623.png)
As the economy continues to run abysmal, this could be the best moment in decades to own gold stocks. And recently hit a new all-time high north $2,000 per ounce. Since bottoming in August of 2018, gold has soared past $1,700 per ounce.